Key result
Myocarditis creates dynamic arrhythmogenic substrates requiring individualized imaging, drug, and device therapies.
Why the study?
Arrhythmias management in myocarditis remains challenging due to variability in patient presentation and disease trajectory.
This review provides a comprehensive overview of the complex arrhythmogenic mechanisms associated with myocarditis, spanning from acute inflammation to chronic fibrotic remodeling, and highlights the need for individualized diagnostic and therapeutic strategies.
Supports individualized myocarditis arrhythmia strategies integrating imaging and therapies; leaves open prospective validation trials.
Myocarditis is an underdiagnosed inflammatory condition ofthe myocardium that may lead to significant complications, including life-threatening ventricular arrhythmias and sudden cardiac death, particularly in young individuals. The arrhythmogenic substrate evolves dynamically across the disease course, driven by acute inflammation, ion channel alterations, immune-mediated cytotoxicity and negative structural remodelling. Persistent myocardial inflammation and fibrosis promote conduction abnormalities, triggered activity and re-entrant circuits, creating a pro-arrhythmic milieu. Despite increasing recognition of its clinical relevance, arrhythmias management in myocarditis remains challenging due to the variability in patient presentation and disease trajectory. This review examines arrhythmogenic mechanisms associated with myocarditis, exploring differential contribution of the above-reported triggers to concurrent electrical instability. Updated therapeutic approaches to managing arrhythmias in myocarditis are discussed, with emphasis on the importance of individualised treatment plans. A deeper understanding of the complex interplay between inflammation and arrhythmias may improve clinical decision-making, and help tailor individualised management strategies for affected patients.
No takes yet. Share an insight, caveat, or question.
Curcio et al. (2026) conducted a review in Myocarditis. Arrhythmia management strategies was evaluated. Myocarditis creates a dynamic arrhythmogenic substrate driven by acute inflammation and chronic fibrosis, requiring individualized management that integrates advanced imaging, antiarrhythmic drugs, and device therapies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: